Squarepoint Ops LLC Unity Biotechnology, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.29 $5,896 - $13,583	10,530 New	10,530 $6,000
Q2 2021 Aug 16, 2021	SELL	$4.15 - $6.3 $61,208 - $92,918	-14,749 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $81,829 - $139,896	-14,851 Reduced 50.17%	14,749 $88,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $101,232 - $188,256	29,600 New	29,600 $155,000
Q3 2020 Nov 16, 2020	SELL	$2.94 - $12.43 $94,900 - $401,227	-32,279 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.28 - $9.67 $36,780 - $67,361	-6,966 Reduced 17.75%	32,279 $280,000
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $77,440 - $117,708	-15,488 Reduced 28.3%	39,245 $228,000
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $247,806 - $346,680	41,370 Added 309.59%	54,733 $395,000
Q3 2019 Nov 14, 2019	BUY	$5.62 - $9.63 $75,100 - $128,685	13,363 New	13,363 $82,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $30M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.